L-Ascorbic Acid Nasal Spray for Patulous Eustachian Tube
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for patulous Eustachian tube disorders and middle ear diseases are ineffective, often causing side effects and failing to address the underlying issues of Eustachian tube incompetence, biofilm protection, and antibiotic resistance, which lead to persistent symptoms and complications such as autophony and otitis media.
Innovation Solution
A composition of L-Ascorbic acid at a pH range of 2.0 to 2.5, applied topically to the nasal mucosa or middle ear, utilizing its antioxidant and surfactant properties to stimulate edema, break down biofilms, and facilitate tissue healing, thereby normalizing Eustachian tube function and reducing inflammatory reactions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional treatments (antibiotics, decongestants, steroids) are used for patulous Eustachian tube disorders, then temporary symptom relief may be achieved, but the treatments are ineffective long-term and cause significant side effects
Solution Approach 1:
The patent changes the chemical parameters of the treatment by using L-Ascorbic acid at a specific pH range (2.0-2.5) and concentration (25-4% wt/volume), which fundamentally alters how the Eustachian tube dysfunction is treated compared to traditional medications, achieving long-term relief without the harmful side effects of conventional treatments
Solution Approach 2:
The patent converts the harmful effect of acid into a beneficial therapeutic agent by using L-Ascorbic acid, which provides both the necessary pH level to stimulate edema and closure of the Eustachian tube, and antioxidant properties to protect tissue while achieving curative effects without traditional medication side effects
2Reliability
If antibiotics are used to treat middle ear infections, then bacterial infections may be eliminated, but antibiotic resistance develops and biofilm protection remains ineffective
Solution Approach 1:
The patent converts the harmful protective barrier of biofilm into a target for destruction by using L-Ascorbic acid's surfactant properties and oxidative mechanisms to break down the biofilm structure, thereby eliminating the protection bacteria rely on and making them vulnerable to elimination without developing resistance
Solution Approach 2:
The patent employs L-Ascorbic acid, a strong antioxidant that functions as a reducing agent to break down biofilm and microbial structures through oxidation-reduction reactions, effectively eliminating microorganisms while avoiding the resistance problem associated with traditional antibiotics
3Productivity
If the Eustachian tube remains open, then air exchange is maintained, but autophony and amplified respiratory sounds occur causing discomfort
Solution Approach 1:
The patent changes the physical state of the Eustachian tube by stimulating edema through pH-induced fluid accumulation, which temporarily increases the tube's resistance to airflow and closes the lumen, thereby eliminating autophony while maintaining the ability to open for air exchange when needed
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution effectively relieves symptoms of patulous Eustachian tube syndrome and middle ear diseases by promoting tissue healing, reducing biofilm adherence, and eliminating microorganisms, offering a safer alternative to antibiotics with minimal side effects.
Implementation Method 1
utilizing its antioxidant and surfactant properties to stimulate edema
Implementation Method 2
utilizing its antioxidant and surfactant properties to stimulate edema, break down biofilms
Implementation Method 3
utilizing its antioxidant and surfactant properties to stimulate edema, break down biofilms, and facilitate tissue healing
Data Source
AI summary
A composition and methods for the treatment of symptoms due to disorders, disease or trauma that impairs normal function of die Eustachian tube and alters vital structures or tissues of the middle ear. This includes diseases and disorders of the Eustachian tube altered by tubal incompetence, inflammatory phenomenon as rhinitis, nasal allergies, infections by microorganisms, tympanic membrane rupture or trauma and variants. The composition is comprised of solution including L-Ascorbic acid and a pharmaceutically acceptable liquid carrier and delivery system. The administration of which is applied topically in appropriate composition and dosage for intranasal or trans tympanic route in the form of drops, spray, aerosol, rinse, douche, gel, or devices.